Alvotech Reports Financial Results for First Quarter of 2024

Total revenues in Q1 2024 increased to $37 million compared to $16 million in the same period last yearGross margin in Q1 2024 increased to $17 million, by $40 million compared to the same period last...

Related Keywords

South Korea , Saudi Arabia , Hong Kong , Canada , Taiwan , Israel , Cambodia , India , Philippines , Singapore , Yangtze River , China General , China , Indonesia , New Zealand , South Africa , Australia , Japan , Bangladesh , United States , Egypt , Ukraine , Pakistan , Malaysia , Vietnam , Republic Of , Thailand , Switzerland , United Kingdom , Joel Morales , Africa , Saval Latin America , Robert Wessman , Teva Pharmaceuticals , Reddy Laboratories Ltd , Instagram , Youtube , Johnson Inc , Facebook , Pharma Corporation Canada , Linkedin , Abbvie Inc , Cigna , Yangtze River Pharmaceutical Group Co Ltd , Quallent Pharmaceuticals , Lotus Pharmaceuticals Co Ltd , Fuji Pharma Co Ltd Japan , Drug Administration , Teva Pharmaceutical Industries Ltd , Amgen Inc , Regeneron Pharmaceuticals Inc , Kamada Ltd , Wednesday May , Chief Financial Officer , Simponi Aria , First Three Months , Regeneron Pharmaceuticals , South America , Teva Pharmaceutical Industries , Advanz Pharma , Cipla Med Pro , Yangtze River Pharmaceutical , Middle East , North Africa , Abdi Ibrahim , Mega Labs , Latin America , Private Securities Litigation Reform Act , Note Regarding Forward Looking , Senior Director , Condensed Consolidated Interim Statements , Condensed Consolidated Interim Statement ,